Detalhe da pesquisa
1.
The Loss of Spatiality and Temporality in Twilight Consciousness: The Emergence of Exogenous Psychosis Induced by Novel Psychoactive Substances.
Psychopathology
; 57(3): 248-258, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38631303
2.
Effects of seasonality in emergency admissions for mental disorders: two years of clinical experience.
Int J Psychiatry Clin Pract
; 28(1): 45-52, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588530
3.
Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia.
J Clin Psychopharmacol
; 43(1): 35-38, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36584247
4.
Dissociation and Temporality in Substance Abuse: A Clinical Phenomenological Overview.
Psychopathology
; : 1-10, 2023 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903485
5.
CANNABIS USE AND SUICIDE IN NON-AFFECTIVE PSYCHOSIS: A MINI-REVIEW OF RECENT LITERATURE.
Psychiatr Danub
; 35(3): 307-319, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37917836
6.
Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms.
Int J Neuropsychopharmacol
; 19(5)2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26775293
7.
BDNF serum levels in subjects developing or not post-traumatic stress disorder after trauma exposure.
Brain Cogn
; 84(1): 118-22, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24362070
8.
Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review.
Healthcare (Basel)
; 12(3)2024 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38338224
9.
Efficacy and suitability of adding short-term psychodynamic psychotherapy (STPP) to pharmacotherapy in patients with depressive disorders: a systematic review.
Trends Psychiatry Psychother
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687843
10.
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation.
J Clin Med
; 13(8)2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38673478
11.
Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study.
Pharmaceuticals (Basel)
; 17(4)2024 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38675495
12.
Enhanced BDNF serum levels in patients with severe pathological gambling.
Addict Biol
; 18(4): 749-51, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22044515
13.
Lurasidone in first-episode psychosis with predominant depressive symptoms: a case report.
Int Clin Psychopharmacol
; 38(4): 275-280, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36853746
14.
Neurotrophic Factors In Cannabis-Induced Psychosis: An Update.
Curr Top Med Chem
; 2023 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37644743
15.
Internet Gaming Disorders and Early Onset Psychosis in Young People: A Case Study and Clinical Observations.
Int J Environ Res Public Health
; 20(5)2023 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900931
16.
First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation and antipsychotic effectiveness.
Psychiatry Res
; 320: 115053, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36682093
17.
Aberrant salience in cannabis-induced psychosis: a comparative study.
Front Psychiatry
; 14: 1343884, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38260781
18.
Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals.
EClinicalMedicine
; 64: 102199, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731936
19.
Lurasidone use in Cannabis-Induced Psychosis: A Novel Therapeutic Strategy and Clinical Considerations in Four Cases Report.
Int J Environ Res Public Health
; 19(23)2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36498129
20.
Remission of persistent methamphetamine-induced psychosis after cariprazine therapy: presentation of a case report.
J Addict Dis
; 40(1): 145-148, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34180372